Dyslipidemia and hypertension: twin killers in renal vascular disease.
Zuccalà
A
A
Department of Nephrology and Urology, Policlinico S. Orsola-Malpighi, Bologna, Italy. azuccala@orsola-malpighi.med.unibo.it
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001057:Apolipoproteins E / Q000235:genetics; D001161:Arteriosclerosis / Q000188:drug therapy / Q000235:genetics; D004656:Enalapril / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics; D007674:Kidney Diseases / Q000188:drug therapy / Q000235:genetics; D051379:Mice; D008817:Mice, Mutant Strains; D019001:Nitric Oxide Synthase / Q000235:genetics
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001057:Apolipoproteins E; D004656:Enalapril; D019001:Nitric Oxide Synthase